GBP1 and cancer: To evaluate whether the GBP1 gene knockout affected the sensitivity of cancer cells to chemotherapy, we assessed cell proliferative ability with different concentrations of docetaxel and paclitaxel (Figures 5A,B) applied in cell culture.